跳至主要内容
临床试验/CTRI/2020/10/028459
CTRI/2020/10/028459招募中未知

The Incidence of Retinopathy in Rheumatic and Musculoskeletal Disease patients on long term Hydroxychloroquine (HCQ) use - A Prospective Study.

Dr Arindam Nandy Roy0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Able to provide signed consent form.
  • Subjects clinically diagnosed to have rheumatic and musculoskeletal diseases.
  • Subjects willing to take HCQ for long duration

排除标准

  • 1. Preexisting ocular conditions of the anterior segment or the retina causing defective vision.
  • 2. Are taking a medication other than HCQ with retinotoxic side effects (Tamoxifen).
  • 3. Known hypersensitivity to 4-aminoquinoline compounds (such as Chloroquine or hydroxychloroquine).
  • 4. Previous exposure to HCQ.

研究者

发起方
Dr Arindam Nandy Roy

相似试验